Postremission therapy in adult acute myeloid leukemia (AML): A randomized comparison between high dose ara-C therapy and conventional consolidation therapy (JALSG AML 201 study).

被引：0
|
作者：
Miyawaki, Shuichi [1 ]
Ohtake, Shigeki [1 ]
Fujisawa, Shin [1 ]
Kiyoi, Hitoshi [1 ]
Shinagawa, Katsuji [1 ]
Usui, Noriko [1 ]
Miyamura, Koichi [1 ]
Nishimura, Miki [1 ]
Miyazaki, Yasushi [1 ]
Nishii, Kazuhiro [1 ]
Nagai, Tadashi [1 ]
Yamane, Takahisa [1 ]
Taniwaki, Masafumi [1 ]
Takahashi, Masatomo [1 ]
Yagasaki, Fumiharu [1 ]
Kimura, Yukihiko [1 ]
Asou, Norio [1 ]
Honda, Sumihisa [1 ]
Ohnishi, Kazunori [1 ]
Naoe, Tomoki [1 ]
Ohno, Ryuzo [1 ]
机构：
[1] Saiseikai Maebashi Hosp, Leukaemia Res Ctr, Maebashi, Gumma, Japan
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2005.2005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2005
引用
收藏
页码：567A / 567A
页数：1
相关论文
共 50 条
  • [1] Long-Term Follow-up of the Randomized JALSG AML 201 Study Comparing High Dose Ara-C Therapy with Conventional Consolidation Therapy in Adult Acute Myeloid Leukemia (AML)
    Miyawaki, Shuichi
    Ohtake, Shigeki
    Fujisawa, Shin
    Kiyoi, Hitoshi
    Shinagawa, Katsuji
    Usui, Noriko
    Miyamura, Kohichi
    Nishimura, Miki
    Miyazaki, Yasushi
    Nishii, Kazuhiro
    Nagai, Tadashi
    Yamane, Takahisa
    Taniwaki, Masafumi
    Takahashi, Masatomo
    Yagasaki, Fumiharu
    Kimura, Yukihiko
    Asou, Norio
    Honda, Sumihisa
    Ohnishi, Kazunori
    Naoe, Tomoki
    Ohno, Ryuzo
    BLOOD, 2008, 112 (11) : 56 - 56
  • [2] Postremission therapy in adult acute myeloid leukemia (AML): A randomized comparison of intensified consolidation therapy without maintenance therapy against conventional consolidation with maintenance therapy -JALSG AML-97 trial.
    Miyawaki, S
    Ohtake, S
    Yagasaki, F
    Mitani, K
    Matsuda, S
    Kishimoto, Y
    Miyazaki, Y
    Asou, N
    Ogawa, Y
    Honda, S
    Ohno, R
    BLOOD, 2004, 104 (11) : 248A - 248A
  • [3] Postremission therapy with one course of high-dose Ara-c for adult acute myeloid leukemia.
    Fagundes, EM
    Glória, ABF
    Viana, MB
    BLOOD, 1999, 94 (10) : 228B - 228B
  • [4] Intermittent intermediate dose ARA-C as consolidation therapy for AML in the elderly.
    Sperr, WR
    Piribauer, M
    Agis, H
    Mitterbauer, M
    Geissler, K
    Haas, O
    Fonatsch, C
    Jager, U
    Schwarzinger, I
    Thalhammer, F
    Valent, P
    Lechner, K
    BLOOD, 1997, 90 (10) : 2267 - 2267
  • [5] Allogeneic bone marrow transplantation compared with high-dose Ara-C postremission therapy in acute myeloid leukemia
    Link, H
    BONE MARROW TRANSPLANTATION, 1998, 22 : S16 - S16
  • [6] A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study
    Miyawaki, Shuichi
    Ohtake, Shigeki
    Fujisawa, Shin
    Kiyoi, Hitoshi
    Shinagawa, Katsuji
    Usui, Noriko
    Sakura, Toru
    Miyamura, Koichi
    Nakaseko, Chiaki
    Miyazaki, Yasushi
    Fujieda, Atsushi
    Nagai, Tadashi
    Yamane, Takahisa
    Taniwaki, Masafumi
    Takahashi, Masatomo
    Yagasaki, Fumiharu
    Kimura, Yukihiko
    Asou, Norio
    Sakamaki, Hisashi
    Handa, Hiroshi
    Honda, Sumihisa
    Ohnishi, Kazunori
    Naoe, Tomoki
    Ohno, Ryuzo
    BLOOD, 2011, 117 (08) : 2366 - 2372
  • [7] Allogeneic bone marrow transplantation compared with high-dose ARA-C postremission therapy in acute myeloid leukemia
    Link, H
    Ehninger, G
    SchonrockNabulsi, P
    Gramatzki, M
    Daoud, A
    Tischler, J
    Brack, N
    Otremba, B
    Lutz, M
    Gackle, R
    Ohl, S
    Heidemann, E
    Gieseler, F
    Loffler, B
    Weiss, J
    Geer, T
    Wandt, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 840 - 840
  • [8] Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study
    Ohtake, Shigeki
    Miyawaki, Shuichi
    Fujita, Hiroyuki
    Kiyoi, Hitoshi
    Shinagawa, Katsuji
    Usui, Noriko
    Okumura, Hirokazu
    Miyamura, Koichi
    Nakaseko, Chiaki
    Miyazaki, Yasushi
    Fujieda, Atsushi
    Nagai, Tadashi
    Yamane, Takahisa
    Taniwaki, Masafumi
    Takahashi, Masatomo
    Yagasaki, Fumiharu
    Kimura, Yukihiko
    Asou, Norio
    Sakamaki, Hisashi
    Handa, Hiroshi
    Honda, Sumihisa
    Ohnishi, Kazunori
    Naoe, Tomoki
    Ohno, Ryuzo
    BLOOD, 2011, 117 (08) : 2358 - 2365
  • [9] A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia - The Japan adult leukemia study group AML97 study
    Miyawaki, S
    Sakamaki, H
    Ohtake, S
    Emi, N
    Yagasaki, F
    Mitani, K
    Matsuda, S
    Kishimoto, Y
    Miyazaki, Y
    Asou, N
    Matsushima, T
    Takahashi, M
    Ogawa, Y
    Honda, S
    Ohno, R
    CANCER, 2005, 104 (12) : 2726 - 2734
  • [10] High dose ARA-C as consolidation therapy for patients with core binding factor acute myeloid leukemia.
    Ferrara, F
    Copia, C
    Palmieri, S
    Annunziata, M
    Pollio, F
    Mele, G
    Schiavone, EM
    BLOOD, 2000, 96 (11) : 326A - 326A
12345